Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erdosteine for cough in acute COPD exacerbations
NCT01176318Phase 4Withdrawn
- Sponsor
- Hull University Teaching Hospitals
- Start
- Aug 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of erdosteine in chronic obstructive pulmonary disease (COPD), sponsored by Hull University Teaching Hospitals. Planned start Aug 2010; status: withdrawn.
02
Drugs
erdosteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01176318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176318.